Although the universal relevance of our findings still awaits verification, our model is supported by data in two cancer cell lines of independent origin, HeLa and A549, that are characterized by high and low propensity for mitotic cell death and recognized as defective or functional in the p53 pathway, respectively. The gene discussed is TP53; the disease is cancer.